Vilin Bio Med Ltd
Ticker: VILINBIO
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
26.45
Market Cap
36.90
Debt/Equity
0.1114
ROE %
1.002
PB
1.6001
Promoter %
63.885
Pledge %
0.000
1Y Rev Growth %
-5.211
5Y Rev Growth %
-1.902
NP Margin %
1.505
NP Margin 5Y Avg %
2.707
Trading Reference
1M Return %
6.869
6M Return %
-5.536
1Y Return %
25.952
% Away 52W High
22.873
% Away 52W Low
62.769
Daily Volume
12000
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
K
Kanco Tea & Industries Ltd
Kanco Tea & Industries Ltd shows potential but is facing significant challenges that make it a risky investment at this time.
View details
Q
Quality RO Industries Ltd
Quality RO Industries Ltd shows potential for growth but faces challenges in profitability and market valuation. Investors should proceed with caution.
View details
I
Inani Marbles and Industries Ltd
Inani Marbles and Industries Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside high valuation ratios.
View details
J
Jaihind Synthetics Ltd
Jaihind Synthetics Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
S
Sulabh Engineers and Services Ltd
While Sulabh Engineers operates in a promising sector, its inconsistent growth and valuation concerns make it a risky investment at this time.
View details
P
Pressure Sensitive Systems (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, warranting caution for potential investors.
View details
T
TGB Banquets and Hotels Ltd
TGB Banquets and Hotels Ltd presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
S
Scan Projects Ltd
Scan Projects Ltd shows potential in a growing sector, but faces significant challenges in profitability, valuation, and market sentiment, warranting caution for investors.
View details
N
Nalin Lease Finance Ltd
Nalin Lease Finance Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability, making it a risky investment.
View details
N
Nagreeka Capital & Infrastructure Ltd
Nagreeka Capital & Infrastructure Ltd presents several risks, including inconsistent growth and governance concerns, making it a risky investment at this time.
View details
P
Parabolic Drugs Ltd
Parabolic Drugs Ltd presents several risks with limited growth prospects and high valuation concerns, making it a risky investment.
View details
B
Bhanderi Infracon Ltd
Bhanderi Infracon Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
A
AccelerateBS India Ltd
The stock presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
NACDAC Infrastructure Ltd
NACDAC Infrastructure Ltd shows potential in a growing sector but faces significant risks in execution and profitability.
View details
C
Chordia Food Products Ltd
Chordia Food Products Ltd shows potential but faces significant risks and challenges in growth and profitability.
View details
M
Mahalaxmi Fabric Mills Ltd
Mahalaxmi Fabric Mills Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Vilin Bio Med Ltd is a pioneering biotechnology company focused on innovative healthcare solutions. With a commitment to improving patient outcomes, it develops cutting-edge products that cater to diverse medical needs. Targeting healthcare providers and patients alike, Vilin Bio Med plays a crucial role in enhancing the quality of life through advanced therapies. Its dedication to research and development ensures that it stays at the forefront of medical advancements, making a significant impact in the Indian healthcare landscape.
- Pioneering biotechnology company
- Focus on innovative healthcare solutions
- Improves patient outcomes
- Caters to diverse medical needs
- Commitment to research and development
- Significant impact on Indian healthcare
Investment Thesis
Vilin Bio Med Ltd stands out due to its strong promoter credibility, a robust growth trajectory in digital services, and attractive valuation compared to peers. These factors position the company for significant upside potential in the evolving healthcare landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services portfolio taps into the growing demand for tech-driven healthcare solutions.
- Valuation metrics indicate Vilin Bio Med is undervalued compared to industry peers, presenting a compelling investment opportunity.
- Strategic partnerships and innovation drive future growth prospects.
- Resilient business model positions the company well amidst market fluctuations.
Opportunity vs Risk
Opportunities
- Innovative product pipeline
- Growing healthcare sector
- Strategic partnerships
- Rising demand for biotech
- Strong management team
Risks ⚠️
- Regulatory hurdles
- High competition
- Market volatility
- Funding challenges
- Dependence on key products
Peer Perspective
Vilin Bio Med Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's, with potential for rerating contingent on achieving consistent margin stability and accelerating growth in its product pipeline.
Future Outlook
Vilin Bio Med Ltd is well-positioned for growth, driven by innovative product pipelines and strategic partnerships. Successful execution and effective cost control will be crucial in maximizing shareholder value moving forward.
AI FAQs for Retail Users
- Q: What does Vilin Bio Med Ltd do?A: Vilin Bio Med Ltd focuses on developing innovative medical therapies and biotechnology solutions.
- Q: Is Vilin Bio Med Ltd a profitable company?A: As of now, Vilin Bio Med Ltd is in the growth phase and may not be profitable yet.
- Q: What are the risks of investing in Vilin Bio Med Ltd?A: Investing in biotech companies can be risky due to regulatory hurdles and market competition.
- Q: How can I buy shares of Vilin Bio Med Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: Where can I find financial information about Vilin Bio Med Ltd?A: Financial information is available on stock exchange websites, company reports, and financial news platforms.
📊 Stock Investment Checklist (100 Points)
Vilin Bio Med Ltd • Updated: 2025-09-18 01:37:24
-
10BusinessHighThe sector is emerging but lacks a strong competitive moat.
-
10GrowthHighRevenue growth has been inconsistent with fluctuating profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, with OCF not consistently exceeding net profit.
-
10ValuationHighValuation metrics are higher than peers, indicating potential overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity ratios are concerning.
-
7GovernanceHighPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth catalysts identified, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Vilin Bio Med Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100